ストックスクリーナーアプリを入手
2.31
1.55%
0.02
前日終値:
$2.33
開ける：
$2.28
24時間の取引高:
10,302
Relative Volume:
0.15
時価総額：
$10.53M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+24.53%
1か月 パフォーマンス:
-35.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.28
$2.36
1週間の範囲:
$1.9599
$2.70
52週間の値動き範囲:
$1.89
$6.48
Newcelx Ltd Stock (NCEL) Company Profile
NCEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NCEL
Newcelx Ltd
|
2.31 | 10.62M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.51 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
798.53 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.02 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.91 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.98 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Newcelx Ltd (NCEL) 最新ニュース
NewcelX appoints Swiss pharma executive to scientific advisory board By Investing.com - Investing.com Nigeria
NewCelX Appoints EY as New Auditor Following Merger - MSN
NewcelX Ltd. Announces Appointment Of Dr. Julien Boisdron To Scientific Advisory Board - marketscreener.com
NewcelX Adds Swiss Diabetes Leader to Advisory Board to Steer IsletRx Program - TipRanks
NewcelX appoints Swiss pharma executive to scientific advisory board - Investing.com
NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board - PR Newswire
What is the current Price Target and Forecast for NewcelX Ltd. (NCEL) - Zacks Investment Research
NewcelX Ltd. (NCEL) Stock Forecast 2026, 2030 & 7-Year Price Prediction | Meyka AI - Meyka
NewcelX Strengthens IP Portfolio with Chinese Patent Publication - TipRanks
NewcelX strengthens IP portfolio with Chinese patent publication - MSN
NewcelX patent for neurological disease treatments published in China - Investing.com
NewcelX patent for neurological disease treatments published in China By Investing.com - Investing.com Canada
NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China - Nasdaq
NewcelX Ltd. (NCEL) -8.5% in After-hours: Decline Amid Routine Trading Conditions - Stocks Telegraph
NLSP SEC FilingsNls Pharmaceutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 - Aktiellt
NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board (PR Newswire) - Aktiellt
NewcelX Ltd.Ordinary Shares (NQ: NCEL - Markets Financial Content
[6-K] NLS Pharmaceutics Ltd. Current Report (Foreign Issuer) | NLSP SEC FilingForm 6-K - Stock Titan
NewcelX appoints ALS specialist to scientific advisory board By Investing.com - Investing.com Nigeria
NewcelX appoints ALS specialist to scientific advisory board - Investing.com
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute - Finviz
NewcelX Appoints Renowned Neurologist to Strengthen Scientific Advisory Board - TipRanks
Price to sales ratio of NewcelX Ltd. – NASDAQ:NCEL - TradingView
Press Release: NewcelX Announces Scientific Leadership With the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board - 富途牛牛
NewcelX Ltd. (NCEL) - Zacks Investment Research
NLS Pharmaceutics to execute 1-for-10 reverse share split - MSN
NewcelX Ltd. (NCEL) company profile and facts - Yahoo Finance UK
NewcelX Announces New CFO Appointment Following Merger - MSN
NewcelX Ltd. (NCEL) interactive stock chart - Yahoo Finance UK
NewcelX Ltd. (NCEL) Stock Forum & Discussion - Yahoo! Finance Canada
NewcelX Ltd (NCEL) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
NewcelX Ltd (NCEL) Stock Earnings Transcripts - GuruFocus
NewcelX appoints Omri Hagai as chief financial officer, effective December 10 By Investing.com - Investing.com Australia
NewcelX appoints Omri Hagai as chief financial officer, effective December 10 - Investing.com India
Neurology expert Prof. Ben-Hur joins NewcelX scientific board By Investing.com - Investing.com Nigeria
NewcelX Ltd. Revenue Breakdown – NASDAQ:NCEL - TradingView
NLS Pharmaceutics Announces Reverse Share Split and Name Change Amid Merger - MSN
NewcelX Ltd. (NCEL) analyst ratings, estimates and forecasts - Yahoo Finance Australia
NewcelX Ltd. (NCEL) Income Statement - Yahoo! Finance Canada
NewcelX Ltd. (NCEL) valuation measures and financial statistics - Yahoo Finance Australia
NCEL Interactive Stock Chart | NewcelX Ltd. Stock - Yahoo Finance
NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board - WV News
Neurology expert Prof. Ben-Hur joins NewcelX scientific board - Investing.com
NewcelX Ltd. (NCEL) Stock Major Holders - Yahoo! Finance Canada
Newcelx Ltd (NCEL) 財務データ
Newcelx Ltd (NCEL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.09%
大文字化:
|
ボリューム (24 時間):